that lung study got me thinking - if you’re measuring biological aging or running recovery protocols, half-life timing matters more than people admit. i wasn’t checking labs after changes for months. just assumed it worked. my endo caught it. here’s the thing: you can’t test inside the active window and see what actually changed baseline. so test timing matters as much as dosing timing. what i do now - log injection day, lock test day gap, one variable at a time. wife calls me out if i’m tweaking everything and expecting results. being able to export the whole log as a pdf for my endo appt was the thing that finally made it click - you see the actual lag between dose and sleep shift, pain trend on 1-10 scale, pattern emerges. makes the whole protocol mean something instead of just hoping. dosing schedule is half the story. when you test is the other half.